- The trend backdrop is active with a 21-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 55.23% based on similar historical setup states.
UPR
ISE
Week ended 07 Aug 2026
Weekly Investor Report
Uniphar plc · Healthcare · Medical Distribution
Latest close
4.26 EUR
0.4%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 1.3% above the Trend Line and sits at 57.0% of its 52-week range. The latest completed week returned 0.4%, after a -7.5% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
47
out of 100
Latest Close
4.26 EUR
7 Aug 2026
1W Return
0.4%
latest completed week
4W Return
-7.5%
short-term follow-through
12W Return
-1.3%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.4%
Latest completed week; four-week move -7.5%.
Indicator stack
83/25
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.23%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
9 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 1.3% above the Trend Line and sits at 57.0% of its 52-week range. The latest completed week returned 0.4%, after a -7.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8712-week average 0.81
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.87Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.5% over four weeks, -1.3% over 12 weeks, and 10.5% over one year. The current trend has remained active for 21 consecutive weeks.
Performance by holding period
Active trend streak21 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.62Latest activity-pressure read.
Pressure change-170.9%Four-week change in activity pressure.
Leadership-6.49Latest relative-leadership reading.
RS change-268.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 9 relevant articles.
1 positive · 8 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-13.7%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+6.6%Week of 17 Apr.
Worst week-5.4%Week of 19 Jun.
Latest week+0.4%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains9
Flat weeks0
Modest losses9
Sharp losses3
Recent vol3.4%13-week weekly-return volatility.
Base vol3.3%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIE Healthcare
4-week rank2 / 2
Group average-5.5%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
IndustryIE Medical Distribution
4-week rank1 / 1
Group average-7.5%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape51/100
Trend, activity pressure, participation, and risk combine to a 51/100 tape read.
Indicator analysis79/100Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 10/12.
Activity pressure 0.87; 2 reversal markers Next-Week ExpectancyPositive 55.23%Next-week expectancy is positive with a 55.23% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 9 relevant articles.
At €4.78, Is It Time To Put Uniphar plc (ISE:UPR) On Your Watch List? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.26 EUR | 0.4% | 4.21 EUR | 3.09 EUR | -0.62 | -6.49 | 1.2M | On |
| 31 Jul 2026 | 4.25 EUR | -4.7% | 4.19 EUR | 3.08 EUR | -0.23 | -1.64 | 1.9M | On |
| 24 Jul 2026 | 4.46 EUR | -1.1% | 4.16 EUR | 3.07 EUR | 0.30 | 2.75 | 1.1M | On |
| 17 Jul 2026 | 4.51 EUR | -2.2% | 4.13 EUR | 3.06 EUR | 0.64 | 3.98 | 693.3K | On |
| 10 Jul 2026 | 4.61 EUR | -3.6% | 4.09 EUR | 3.05 EUR | 0.87 | 3.85 | 804.6K | On |
| 3 Jul 2026 | 4.78 EUR | 4.6% | 4.06 EUR | 3.04 EUR | 1.11 | 7.31 | 369.0K | On |
| 26 Jun 2026 | 4.57 EUR | -1.8% | 4.02 EUR | 3.03 EUR | 1.12 | 2.70 | 322.6K | On |
| 19 Jun 2026 | 4.66 EUR | -5.4% | 3.99 EUR | 3.02 EUR | 1.24 | 5.72 | 364.9K | On |
| 12 Jun 2026 | 4.92 EUR | 2.8% | 3.96 EUR | 3.01 EUR | 1.45 | 14.11 | 1.9M | On |
| 5 Jun 2026 | 4.79 EUR | 4.9% | 3.92 EUR | 2.99 EUR | 1.31 | 14.41 | 255.9K | On |
| 29 May 2026 | 4.56 EUR | 0.9% | 3.88 EUR | 2.98 EUR | 1.24 | 8.60 | 2.3M | On |
| 22 May 2026 | 4.52 EUR | 4.6% | 3.86 EUR | 2.98 EUR | 1.10 | 9.55 | 6.0M | On |
| 15 May 2026 | 4.32 EUR | 0.6% | 3.84 EUR | 2.97 EUR | 0.81 | 10.09 | 1.8M | On |
| 8 May 2026 | 4.29 EUR | 3.2% | 3.83 EUR | 2.96 EUR | 0.80 | 6.95 | 1.9M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.